Impact of iPUMP on Allergy Treatment Adherence

This report presents the findings of the SPEED survey conducted by AplusA for Stallergenes Greer, which evaluates the impact of the iPUMP® connected assistant on adherence to sublingual liquid immunotherapy (SLIT). The survey, involving 181 patients, revealed a 15% increase in treatment adherence among users of iPUMP®. Notably, parental involvement in treatment administration for children aged 5 to 12 decreased significantly, while the percentage of children independently managing their medication increased. The report details how iPUMP® supports personalized SLIT treatments by ensuring correct dosing techniques and monitoring treatment adherence through a connected mobile application. The findings will be presented at the CFA congress in Paris, highlighting the role of connected health solutions in enhancing treatment adherence and patient confidence. The results underscore the importance of digital health innovations in improving patient outcomes and fostering broader adoption of such technologies in allergy management.